Huapont Life Sciences (002004.SZ) announced its semi-annual report for the year 2024, with total revenue of 5.922 billion yuan, a year-on-year increase of 0.91%; net income attributable to shareholders of the listed company was 0.314 billion yuan, a year-on-year decrease of 19.02%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.296 billion yuan, a year-on-year decrease of 21.64%; basic earnings per share was 0.1586 yuan.
华邦健康(002004.SZ)：上半年净利润3.14亿元，同比下降19.02%
huapont life sciences (002004.SZ): the net income in the first half of the year was 0.314 billion yuan, a decrease of 19.02% year-on-year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated